Valuation: HPGC Renmintongtai Pharmaceutical Corporation

Market Cap 5.47B 815M 718M 680M 614M 1.16B 78.17B 1.17B 8.14B 3.13B 39.96B 3.06B 2.99B 128B P/E 2024
20.4x
P/E 2025 46.8x
Enterprise Value 4.97B 740M 652M 618M 558M 1.05B 70.98B 1.06B 7.39B 2.84B 36.28B 2.78B 2.72B 116B EV / Sales 2024
0.41x
EV / Sales 2025 0.56x
Free-Float
24.73%
Yield 2024 *
-
Yield 2025 -
09-21 HPGC Renmintongtai Pharmaceutical Corporation(XSSC:600829) added to S&P Global BMI Index CI
08-07 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 CI
04-16 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-10 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
20/10/25 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
08/08/25 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2025 CI
18/04/25 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
14/04/25 HPGC Renmintongtai Pharmaceutical Flags 21 Million Yuan Reduction in 2024 Profit MT
11/04/25 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2024 CI
21/10/24 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
08/08/24 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2024 CI
19/04/24 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
27/03/24 HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
1 day+1.07%
1 week-2.68%
1 month-6.73%
3 months+21.52%
6 months-7.46%
Current year-12.77%
1 week 9.28
Extreme 9.28
9.73
1 month 9.17
Extreme 9.17
10.53
Current year 7.54
Extreme 7.54
13.16
1 year 7.54
Extreme 7.54
18.13
3 years 4.96
Extreme 4.96
18.13
5 years 4.96
Extreme 4.96
18.13
10 years 4.88
Extreme 4.88
18.13
Manager TitleAgeSince
Chief Executive Officer 57 26/09/2016
Director of Finance/CFO 54 07/04/2022
Investor Relations Contact - -
Director TitleAgeSince
Chairman 57 15/12/2023
Director/Board Member 51 26/12/2023
Director/Board Member 56 26/12/2023
Change 5-day change 1-year change 3-year change Capi.($)
+1.07%-2.68%+19.52%+19.97% 815M
-0.66%+0.53%+51.65%+115.42% 1,031B
-0.58%-1.65%+42.78%+69.98% 638B
-0.28%-1.32%+12.98%+75.49% 462B
-0.39%-1.87%+73.13%+41.15% 359B
+0.40%-3.41%+24.34%+41.50% 335B
-0.88%-0.10%+14.25%+27.28% 273B
-0.78%-2.06%-2.34%+10.91% 253B
-0.72%+3.80%+49.37%+56.84% 228B
-0.37%-1.53%+34.28%+98.89% 185B
Average -0.26%-0.60%+31.99%+55.74% 376.47B
Weighted average by Cap. -0.41%-0.35%+37.67%+71.37%

Financials

2024 2025
Net sales 10.05B 1.5B 1.32B 1.25B 1.13B 2.13B 144B 2.15B 14.95B 5.75B 73.43B 5.62B 5.5B 235B 10.38B 1.55B 1.36B 1.29B 1.17B 2.2B 148B 2.22B 15.45B 5.94B 75.84B 5.81B 5.68B 243B
Net income 213M 31.79M 28M 26.53M 23.95M 45.14M 3.05B 45.72M 317M 122M 1.56B 119M 117M 5B 134M 19.95M 17.57M 16.65M 15.03M 28.33M 1.91B 28.69M 199M 76.65M 978M 74.92M 73.29M 3.14B
Net Debt -200M -29.77M -26.21M -24.84M -22.42M -42.26M -2.85B -42.81M -297M -114M -1.46B -112M -109M -4.68B -503M -74.99M -66.04M -62.57M -56.49M -106M -7.19B -108M -749M -288M -3.68B -282M -275M -11.79B
Logo HPGC Renmintongtai Pharmaceutical Corporation
HPGC Renmintongtai Pharmaceutical Corp is a China-based company principally engaged in pharmaceutical wholesale, pharmaceutical retail, medical services, and pharmaceutical logistics businesses. The Company's pharmaceutical wholesale business is operated by its medicine branch and new and special drug branch, mainly providing delivery services for pharmaceuticals, medical devices, and health food through a pure sales model supported by allocation services. The Company's main products include chemical drugs, proprietary Chinese medicines, biological products, medical devices, Chinese herbal pieces, health food, daily necessities, glass instruments, and chemical reagents.
Employees
2,735
Date Price Change Volume
30/09/26 CN¥9.430 +1.07% 6,904,682
29/09/26 CN¥9.330 -0.74% 5,903,495
28/09/26 CN¥9.400 -2.29% 8,239,978
24/09/26 CN¥9.620 -0.72% 10,896,300
23/09/26 CN¥9.690 -4.06% 11,967,700
  1. Stock Market
  2. Stocks
  3. 600829 Stock